Literature DB >> 26278665

Evaluation of central pancreatectomy and pancreatic enucleation as pancreatic resections--A comparison.

Steffen Wolk1, Marius Distler2, Stephan Kersting3, Jürgen Weitz2, Hans-Detlev Saeger2, Robert Grützmann2.   

Abstract

INTRODUCTION: For minor pancreatic resection such as enucleation (PE) and central pancreatectomy (CP) comparative data are rare. These techniques provide parenchyma-sparing alternatives to major resections (e.g. pancreaticoduodenectomy) for neuroendocrine tumors, cystic tumors or metastases. This study retrospectively compares the morbidity and mortality of both techniques, with special regard to the formation of postoperative pancreatic fistulas (POPF).
METHODS: Between December 1996 and November 2013 the postoperative events and clinical outcomes of 17 patients after pancreatic enucleation and 26 patients after central pancreatectomy were retrospectively analyzed from a prospectively collected database.
RESULTS: Perioperative mortality was 0% in both groups. There was no significant difference in the overall peri-operative morbidity (CP 80.8% vs. PE 82.4%). The major cause of the high morbidity was the formation of a POPF with 26.9% of the patients after CP and 35.3% after PE. Univariate analysis showed a BMI over 30 kg/m(2) in the CP group to be an independent risk factor. Additional minor complications, e.g. urinary tract infection, pleural effusion, etc. furthermore contributed to the perioperative morbidity.
CONCLUSION: PE and central CP are feasible techniques for selected patients, but the indications are limited. Morbidity after these resections is high with the major cause being the development of a POPF.
Copyright © 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Central pancreatectomy; Insulinoma; Pancreatic enucleation; Pancreatic fistula; Pancreatic surgery

Mesh:

Year:  2015        PMID: 26278665     DOI: 10.1016/j.ijsu.2015.07.712

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  7 in total

1.  Open and minimally invasive pancreatic neoplasms enucleation: a systematic review.

Authors:  Raffaele Dalla Valle; Elena Cremaschi; Laura Lamecchi; Francesca Guerini; Edoardo Rosso; Maurizio Iaria
Journal:  Surg Endosc       Date:  2019-07-30       Impact factor: 4.584

2.  Perioperative application of somatostatin analogs for pancreatic surgery-current status in Germany.

Authors:  Andreas Volk; Philipp Nitschke; Franziska Johnscher; Nuh Rahbari; Thilo Welsch; Christoph Reißfelder; Jürgen Weitz; Marius Distler; Soeren Torge Mees
Journal:  Langenbecks Arch Surg       Date:  2016-09-15       Impact factor: 3.445

Review 3.  [Minimally invasive and robot-assisted surgery for pancreatic cystic tumors].

Authors:  T Welsch; M Distler; J Weitz
Journal:  Chirurg       Date:  2017-11       Impact factor: 0.955

4.  Application of End-to-end Anastomosis in Robotic Central Pancreatectomy.

Authors:  Rong Liu; Zi-Zheng Wang; Yuan-Xing Gao; Yong Xu
Journal:  J Vis Exp       Date:  2018-06-02       Impact factor: 1.355

5.  Minimally Invasive Versus Open Treatment for Benign Sporadic Insulinoma Comparison of Short-Term and Long-Term Outcomes.

Authors:  Giulio Belfiori; Dominik Wiese; Stefano Partelli; Sabine Wächter; Elisabeth Maurer; Stefano Crippa; Massimo Falconi; Detlef K Bartsch
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

6.  Total laparoscopic duodenum-preserving pancreatic head resection for solid pseudopaillary neoplasm of pancreas: A case report.

Authors:  Bin Liang; Yuanyuan Chen; Mengyang Li; Xiaofeng Dong; Siyang Yao; Tianqi Liu
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

7.  Total laparoscopic central pancreatectomy with Roux-Y pancreaticojejunostomy for solid pseudopapillary neoplasm of pancreas: A case report.

Authors:  Bin Liang; Yuanyuan Chen; Mengyang Li; Xiaofeng Dong; Siyang Yao; Tianqi Liu
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.